InstaMed® Pharmaceuticals, an advanced biotechnology company transforming peptide delivery through its patented InstaRelease® oral dissolving strip platform, announced the appointment of Tracy Gibbs, PhD, as Chief Executive Officer. The leadership...
not recommend speciation prior to first-line therapy. Additional Candida speciation or susceptibility testing should be performed if there is persistent or recurrent infection defined by three or more episodes of symptomatic CV within one year or...
dysfunction. Its principal programs are ViraxImmune™, an in-development T cell-based immune profiling and diagnostic platform, and ImmuneSelect, a research-use-only portfolio of peptide pools, ELISpot plates and related immune reagents. For more...
brought Children's Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, please visit https://www.chop.edu.
that effectively detect, diagnose and treat health conditions and raise the standard of care around the world. For more information please visit www.hologic.com
growth and skeletal health outcomes in children with achondroplasia. About Achondroplasia Achondroplasia, the most common form of skeletal dysplasia leading to disproportionate short stature in humans, is characterized by slowing of endochondral...
access to the first von Willebrand Factor (VWF) concentrate indicated for prophylactic treatment across all ages and forms of VWD, the most common inherited bleeding disorder.ii The expanded label is based on data from the Phase 3 WIL-33 clinical...
Spectrum Science, an independent, full-service, strategic platform offering integrated clinical, commercial, and communications services, announced the appointment of Marie Emms as President of its clinical trial recruitment and retention...
quality, laboratory confirmation, and defensibility they expect from Omega." Omega's laboratory-based breath testing is performed using mass spectrometry, a gold-standard analytical approach for confirming the presence of targeted analytes. The...
the topical treatment of atopic dermatitis in adults and pediatric patients 2 years of age and older SELECTED SAFETY INFORMATION Adverse Events: In plaque psoriasis, the most common adverse reactions (incidence ≥1%) were: folliculitis,...
fixed-duration TEPKINLY in combination with R2 compared to standard of care R2. "Follicular lymphoma is a persistent form of cancer that remains incurable, which means patients need more treatment options. Patients often relapse and experience...
including the launch of the Omnicell Titan XT automated dispensing system and expansion of the cloud-native OmniSphere platform. “Since joining Omnicell in 2024, Nnamdi has made a significant strategic impact on the Company, working to strengthen...
to help patients get authentic, FDA-approved medicines without having to turn to unsafe alternatives. For more information about the Medicare GLP-1 Bridge, patients are encouraged to speak with their healthcare professional. If you need support or...
building the world’s first fully autonomous robotic pharmacy, emerged from stealth with a working system designed to transform how prescriptions are dispensed, verified and delivered. The company recently closed an oversubscribed $12.6 million seed...
facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications. For more information, please visit www.avenacy.com.
Johnson & Johnson announced the commercial launch of the Dual Energy THERMOCOOL SMARTTOUCH SF (DE STSF) Platform in Europe, expanding physician access to a dual-energy catheter ablation solution designed for personalized care across workflows,...
to traditional cell block methods, which convert concentrated cells suspended in fluid into a paraffin-embedded format for slide-based evaluation, the patent‑pending CytoPath Disc offers a more streamlined and efficient approach. The CytoPath Disc...
chief executive officer, Ionis. “TRYNGOLZA reflects the strength of Ionis’ innovative science and our commitment to transforming patients’ lives. As our first independent launch in a prevalent disease, this milestone builds on our success in...
chief executive officer, Ionis. “TRYNGOLZA reflects the strength of Ionis’ innovative science and our commitment to transforming patients’ lives. As our first independent launch in a prevalent disease, this milestone builds on our success in...
Cohen, Medical Director of HOPE Therapeutics, comments: "The continued evolution of precision TMS technology is transforming what's possible in psychiatric care. I am inspired by the increased accuracy, reliability and personalized care that these...
